TWELVE YEARS OF EXPERIENCE USING CHOLECYSTOJEJUNAL BY-PASS FOR PALLIATIVE TREATMENT OF ADVANCED PANCREATIC CANCER

Autor: Marcos Belotto de OLIVEIRA, Bruna do Nascimento SANTOS, André de MORICZ, Adhemar Monteiro PACHECO-JUNIOR, Rodrigo Altenfelder SILVA, Renata D’Alpino PEIXOTO, Tércio De CAMPOS
Jazyk: English<br />Portuguese
Rok vydání: 2017
Předmět:
Zdroj: ABCD: Arquivos Brasileiros de Cirurgia Digestiva, Vol 30, Iss 3, Pp 201-204 (2017)
Druh dokumentu: article
ISSN: 0102-6720
DOI: 10.1590/0102-6720201700030009
Popis: ABSTRACT Background: The cholecistojejunal bypass is an important resource to treat obstructive jaundice due to advanced pancreatic cancer. Aim: To assess the early morbidity and mortality of patients with pancreatic cancer who underwent cholecystojejunal derivation, and to assess the success of this procedure in relieving jaundice. Method: This retrospective study examined the medical records of patients who underwent surgery. They were categorized into early death and non-early death groups according to case outcome. Results: 51.8% of the patients were male and 48.2% were female. The mean age was 62.3 years. Early mortality was 14.5%, and 10.9% of them experienced surgical complications. The cholecystojejunostomy procedure was effective in 97% of cases. There was a tendency of increased survival in women and patients with preoperative serum total bilirubin levels below 15 mg/dl. Conclusion: Cholecystojejunal derivation is a good therapeutic option for relieving jaundice in patients with advanced pancreatic cancer, with acceptable rates of morbidity and mortality.
Databáze: Directory of Open Access Journals